検索
Neumora Therapeutics Inc
NMRAウォッチリストに追加
1.670USD
+0.050+3.09%
終値 07/02, 13:00（ET）15分遅れの株価
304.20M時価総額
損失額直近12ヶ月PER
株主
更新時刻: Thu, May 14
更新時刻: Thu, May 14
株主統計
種類
株主統計
株主統計
比率
Amgen Inc
19.09%
ARCH Venture Partners
18.27%
Invus Public Equities Advisors, LLC
4.59%
Berns (Paul L)
4.16%
SB Global Advisers Ltd
3.47%
他の
50.43%
株主統計
株主統計
比率
Amgen Inc
19.09%
ARCH Venture Partners
18.27%
Invus Public Equities Advisors, LLC
4.59%
Berns (Paul L)
4.16%
SB Global Advisers Ltd
3.47%
他の
50.43%
種類
株主統計
比率
Investment Advisor
21.86%
Venture Capital
19.33%
Corporation
19.09%
Hedge Fund
7.86%
Individual Investor
4.52%
Investment Advisor/Hedge Fund
2.61%
Endowment Fund
1.79%
Research Firm
1.37%
Pension Fund
0.12%
他の
21.45%
機関投資家保有株
更新時刻: Wed, Apr 1
更新時刻: Wed, Apr 1
報告期間
機関投資家数
保有株式数
比率
変動額
2026Q1
301
106.55M
57.52%
-16.54M
2025Q4
291
86.53M
52.51%
-28.54M
2025Q3
293
86.79M
53.64%
-40.47M
2025Q2
288
142.02M
87.70%
-25.57M
2025Q1
283
144.00M
90.43%
+12.16M
2024Q4
249
161.18M
99.54%
+45.20M
2024Q3
201
148.65M
93.66%
+40.67M
2024Q2
179
142.61M
90.03%
+47.65M
2024Q1
154
133.89M
85.01%
+50.39M
2023Q4
108
122.49M
78.90%
+50.97M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Amgen Inc
35.37M
19.43%
--
--
Apr 10, 2025
ARCH Venture Partners
33.85M
18.59%
+1.92M
+6.00%
Oct 27, 2025
Invus Public Equities Advisors, LLC
9.00M
4.94%
+2.71M
+43.08%
Feb 13, 2026
Berns (Paul L)
7.67M
4.21%
-9.82K
-0.13%
Feb 17, 2026
SB Global Advisers Ltd
6.43M
3.53%
-111.47K
-1.70%
Dec 31, 2025
MIC Capital Management UK LLP
4.46M
2.45%
--
--
Dec 31, 2025
Point72 Asset Management, L.P.
3.67M
2.02%
+3.67M
--
Dec 31, 2025
Millennium Management LLC
3.62M
1.99%
+1.61M
+80.08%
Dec 31, 2025
Fidelity Management & Research Company LLC
3.50M
1.92%
-3.46K
-0.10%
Dec 31, 2025
詳細を見る
関連ETF
更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
Invesco Nasdaq Biotechnology ETF
0.05%
ProShares Ultra Nasdaq Biotechnology
0.04%
Invesco RAFI US 1500 Small-Mid ETF
0.02%
iShares Biotechnology ETF
0.02%
Schwab U.S. Small-Cap ETF
0.01%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
0%
iShares US Small-Cap Equity Factor ETF
0%
Virtus LifeSci Biotech Clinical Trials ETF
0%
Fidelity MSCI Health Care Index ETF
0%
Schwab U.S. Broad Market ETF
0%
詳細を見る
Invesco Nasdaq Biotechnology ETF
比率0.05%
ProShares Ultra Nasdaq Biotechnology
比率0.04%
Invesco RAFI US 1500 Small-Mid ETF
比率0.02%
iShares Biotechnology ETF
比率0.02%
Schwab U.S. Small-Cap ETF
比率0.01%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
比率0%
iShares US Small-Cap Equity Factor ETF
比率0%
Virtus LifeSci Biotech Clinical Trials ETF
比率0%
Fidelity MSCI Health Care Index ETF
比率0%
Schwab U.S. Broad Market ETF
比率0%